19 March, 2026
"Daffodil Day has meaning for us all. So many of us have been affected by cancer through family and friends in addition to our patients.
It reminds us of the strength of those living with cancer and inspires us to keep pushing for better treatments, better supports and better outcomes for all" - Dr Emily Harrold, Consultant Medical Oncologist and Co-Director, Young Onset Cancer Programme
The Young Onset Cancer Programme at Trinity St James’s Cancer Institute (TSJCI) is dedicated to supporting people diagnosed with cancer between the ages of 25-50, often in the midst of careers, education, relationships, and family life. Young adults can face unique challenges, including concerns about fertility, body image, long‑term side effects, financial pressures, and balancing treatment with work and family responsibilities. This programme brings together expert clinical teams to provide tailored care, ensuring that patients <50 years of age receive the specialised support, guidance, and information they need at every stage of their cancer journey.
Through personalised assessment, coordinated care pathways, and access to age‑specific supports, the programme works to address the medical, psychological, and social needs of young adults. It also plays a vital role in advancing research into the causes and characteristics of cancer in patients under the age of 50, helping to improve understanding, refine treatment approaches, and drive earlier detection. By listening closely to patient experiences, the Young Onset Cancer Programme continues to evolve, ensuring that services remain responsive, inclusive, and focused on quality of life, both during and after treatment.
On Daffodil Day, we recognise the strength and resilience of younger adults facing cancer, and we acknowledge the essential work of the Young Onset Cancer Programme in shaping better outcomes for this growing population. Their stories remind us why investment in specialised care and research is so important. By supporting initiatives like this, we can create a future where every patient diagnosed with cancer receives the personalised, compassionate, and forward‑thinking care they deserve.